These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 18377852)

  • 1. NCCN Task Force Report: Oral chemotherapy.
    Weingart SN; Brown E; Bach PB; Eng K; Johnson SA; Kuzel TM; Langbaum TS; Leedy RD; Muller RJ; Newcomer LN; O'Brien S; Reinke D; Rubino M; Saltz L; Walters RS
    J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 3():S1-14. PubMed ID: 18377852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of oral medications in patients with advanced breast cancer.
    Palmieri FM; Barton DL
    Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S17-22. PubMed ID: 18054678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are patients on oral chemotherapy in your practice setting safe?
    Moody M; Jackowski J
    Clin J Oncol Nurs; 2010 Jun; 14(3):339-46. PubMed ID: 20529795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCCN Task Force Report. prevention and management of mucositis in cancer care.
    Bensinger W; Schubert M; Ang KK; Brizel D; Brown E; Eilers JG; Elting L; Mittal BB; Schattner MA; Spielberger R; Treister NS; Trotti AM
    J Natl Compr Canc Netw; 2008 Jan; 6 Suppl 1():S1-21; quiz S22-4. PubMed ID: 18289497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.
    Bedell CH
    Clin J Oncol Nurs; 2003; 7(6 Suppl):5-9. PubMed ID: 14705494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral chemotherapy medications: the need for a nurse's touch.
    Winkeljohn DL
    Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues related to overadherence to oral chemotherapy or targeted agents.
    Spoelstra SL; Given BA; Given CW; Grant M; Sikorskii A; You M; Decker V
    Clin J Oncol Nurs; 2013 Dec; 17(6):604-9. PubMed ID: 24113679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to oral cancer therapies: nursing interventions.
    Winkeljohn D
    Clin J Oncol Nurs; 2010 Aug; 14(4):461-6. PubMed ID: 20682501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacoeconomic aspects of oral cytostatic agents].
    Poquet Jornet JE; Carrera-Hueso FJ; Gasent Blesa JM; Peris Godoy M
    Farm Hosp; 2011 May; 35 Suppl 2():25-31. PubMed ID: 22445506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions and experiences of patients receiving oral chemotherapy.
    Simchowitz B; Shiman L; Spencer J; Brouillard D; Gross A; Connor M; Weingart SN
    Clin J Oncol Nurs; 2010 Aug; 14(4):447-53. PubMed ID: 20682500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing strategies for patients on oral chemotherapy.
    Hollywood E; Semple D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):37-9; discussion 40. PubMed ID: 11219976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe administration of oral chemotherapy.
    Birner A
    Clin J Oncol Nurs; 2003; 7(2):158-62. PubMed ID: 12696211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There's many a slip twixt cup and lip: adherence issues in cancer therapy.
    Fallowfield L
    Nat Clin Pract Oncol; 2008 Mar; 5(3):118-9. PubMed ID: 18212767
    [No Abstract]   [Full Text] [Related]  

  • 16. A review on adherence management in patients on oral cancer therapies.
    Wood L
    Eur J Oncol Nurs; 2012 Sep; 16(4):432-8. PubMed ID: 22051845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient adherence and persistence with oral anticancer treatment.
    Ruddy K; Mayer E; Partridge A
    CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
    Arbuckle RB; Griffith NL; Iacovelli LM; Johnson PE; Jorgenson JA; Kloth DD; Lucarelli CD; Muller RJ
    Pharmacotherapy; 2008 May; 28(5 Pt 2):1S-15S. PubMed ID: 18447704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient adherence with oral oncolytic therapies.
    Vioral A; Leslie M; Best R; Somerville D
    Semin Oncol Nurs; 2014 Aug; 30(3):190-9. PubMed ID: 25085031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.